Farrow Jeffrey S bought TARS
March 5, 2026 · Form 4 insider transaction
Farrow Jeffrey S bought 30,724 shares of Tarsus Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
30,724
Price
$0.00
Total value
N/A
InsiderFarrow Jeffrey S
RoleDirector
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateMarch 5, 2026
Filing dateMarch 9, 2026
Shares owned after30,724
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
25% of the option shares shall vest on March 5, 2027, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years, subject to the Reporting Person's continuous service.